ALLMedicine™ Helicobacter Pylori Infection Center

Mar 26th, 2023 - Gastric atrophy (GA), usually linked to chronic infection with Helicobacter pylori (H. pylori), may over time evolve into gastric malignancy. Besides H. pylori, high salt intake may play a role in GA development. This study evaluates cross section...

Mar 25th, 2023 - Gastric cancer remains a major cause of cancer-related mortality worldwide. The temporal trends for this malignancy, however, are dynamic, and reports from the past decade indicate important declines in some regions and demographic groups, as well...

Mar 25th, 2023 - The efficacy of vonoprazan compared with that of proton pump inhibitors in clarithromycin-based bismuth-containing quadruple therapy has not been fully demonstrated. This study aimed to evaluate the efficacy and safety of vonoprazan-based versus p...

Mar 22nd, 2023 - Helicobacter pylori infection is the most common cause of infectious diseases worldwide, and management is a current and vital problem for physicians and patients. One of the online platforms that people use most to access health information is Yo...

Mar 21st, 2023 - In this multicenter, open-label, randomized trial, we recruited adult H. pylori-infected patients from nine centers in Taiwan. Subjects were randomly assigned (1:1:1) to 14-day hybrid therapy, 14-day high-dose dual therapy or 10-day bismuth quadru...

Sep 30th, 2021 - Functional dyspepsia (FD) is one of the most common conditions in clinical practice. In spite of its prevalence, FD is associated with major uncertainties in terms of its definition, underlying pathophysiology, diagnosis, treatment, and prognosis....

Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...

Feb 2nd, 2021 - The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consider...

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

May 26th, 2017 - Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediat...

Mar 10th, 2023 - This study will invite patients who need to undergo urea breath test, upper gastrointestinal endoscopy and histology examination, and collect their tests results, upper gastrointestinal endoscopy images and histopathological results. We use convol...

Mar 8th, 2023 - Background: Bismuth quadruple therapy is currently the recommended first-line regimen for Helicobacter pylori (H. pylori) infection in regions with high clarithromycin resistance. Recent randomized trials showed that 7-day vonoprazan-based triple ...

Mar 1st, 2023 - Abstract Introduction: H. pylori selectively infects the human stomach mucosa, being the most prevalent chronic infection in the world. Its prevalence correlates with socioeconomic factors and it is higher in older individuals. H. pylori presence ...

Feb 16th, 2023 - The eradication rate of H. pylori is decreasing year by year due to the occurrence of bacterial resistance, especially clarithromycin, one of the most widely-used antimicrobials against H. pylori. Understanding antibiotic resistance before treatme...

Feb 14th, 2023 - In France, every year 1 million people are explored for Helicobacter pylori infection and 200,000 receive eradication treatment. Faced with the high prevalence of Hp resistance to antibiotics, the Haute Autorité de Santé (HAS) has recommended sinc...

Nov 22nd, 2022 - Key clinical point: Patients with histological intestinal metaplasia (IM) before eradication of Helicobacter pylori infection, especially at the corpus lesser curvature, may be at an increased risk for gastric cancer after successful eradication.

Oct 26th, 2022 - Key clinical point: Helicobacter pylori (HP) infection is associated with the tumor expression of programmed death ligand-1 (PD-L1) in patients with gastric cancer. Major finding: HP infection was significantly associated with the tumor expression.

Oct 18th, 2022 - The oral potassium-competitive acid blocker (PCAB) vonoprazan was noninferior and superior to the proton pump inhibitor (PPI) lansoprazole for erosive esophagitis, according to results of the phase 3 PHALCON-EE trial. Vonoprazan achieved higher ra...

Sep 27th, 2022 - Gastroenterology August 2022 Johnson-Laghi KA, Mattar MC. Integrating cognitive apprenticeship into gastroenterology clinical training.

Sep 27th, 2022 - Gastroenterology August 2022 Johnson-Laghi KA, Mattar MC. Integrating cognitive apprenticeship into gastroenterology clinical training.